Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
메토트렉세이트 치료에 실패한 류마티스관절염 환자에서 에타너셉트 사용에 대한 비용-효과 분석Cost-Effectiveness Analysis of Etanercept in the Treatment of Methotrexate-resistant Rheumatoid Arthritis
- Other Titles
- Cost-Effectiveness Analysis of Etanercept in the Treatment of Methotrexate-resistant Rheumatoid Arthritis
- Issue Date
- Apr-2006
- Publisher
- 대한약학회
- Keywords
- rheumatoid arthritis; cost-effectiveness analysis; pharmacoeconomics; etanercept
- Citation
- 약 학 회 지, v.50, no.2, pp 70 - 77
- Pages
- 8
- Journal Title
- 약 학 회 지
- Volume
- 50
- Number
- 2
- Start Page
- 70
- End Page
- 77
- ISSN
- 0377-9556
- Abstract
- A cost effective analysis was performed for comparing leflunomide+methotrexate, etanercept monotherapy and etanercept+methotrexate for 6 months. For the patients with methotrexate-resistant RA, ACR20 data were extracted from the published clinical trials searched from Pubmed. The direct medical cost was estimated based on ACR guideline and Korean National Health Insurance reimbursement. Combination therapy of etanercept+methotrexate was found to be more cost-effective than etanercept monotherapy, which meant it was a better therapeutic strategy for methotrexate- resistant RA.
- Files in This Item
- Go to Link
- Appears in
Collections - 특수대학원 > 임상약학대학원 > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.